MedPath

哈尔滨三三药业有限公司

Ownership
-
Established
1998-09-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Roxithromycin for Suspension

Product Name
罗红霉素干混悬剂
Approval Number
国药准字H20058650
Approval Date
Jul 7, 2024
NMPA

Roxithromycin for Suspension

Product Name
罗红霉素干混悬剂
Approval Number
国药准字H20058651
Approval Date
Jul 7, 2024
NMPA

Erythromycin Ethylsuccinate Tablest

Product Name
琥乙红霉素片
Approval Number
国药准字H23020425
Approval Date
Jul 23, 2020
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H23020421
Approval Date
Jul 9, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H23020419
Approval Date
Jul 9, 2020
NMPA

Compound Suifamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H23020416
Approval Date
Jul 9, 2020
NMPA

Cefixime Capsules

Product Name
勤克沃
Approval Number
国药准字H20040323
Approval Date
Jul 9, 2020
NMPA

Ethambutol Hydrochloride Tablets

Product Name
盐酸乙胺丁醇片
Approval Number
国药准字H23020420
Approval Date
Jul 9, 2020
NMPA

Cefalexin Tables

Product Name
头孢氨苄片
Approval Number
国药准字H23020417
Approval Date
Jul 9, 2020
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H23020415
Approval Date
Jul 9, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.